Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Gilead Sciences logoGilead Sciences GILD

Gilead said it issued 4 series of senior notes in connection with the Tenth Supplemental Indenture, including 4.80% notes due 2029 at $750,000,000, 5.10% notes due 2035 at $1,000,000,000, 5.50% notes due 2054 at $1,000,000,000 and 5.60% notes due 2064 at $750,000,000.

8-KEntry into a Material Definitive AgreementFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Gilead said it issued 4 series of senior notes in connection with the Tenth Supplemental Indenture, including 4.80% notes due 2029 at $750,000,000, 5.10% notes due 2035 at $1,000,000,000, 5.50% notes due 2054 at $1,000,000,000 and 5.60% notes due 2064 at $750,000,000.

  2. The company said the notes due 2029 pay interest at 4.80% a year, the notes due 2035 at 5.10%, the notes due 2054 at 5.50% and the notes due 2064 at 5.60%, with interest paid semi-annually.

  3. The company said it intends to use the net proceeds from the notes for general corporate purposes, which may include repaying indebtedness. It said the indenture contains provisions that restrict secured indebtedness, sale and leaseback transactions, and consolidations, mergers or asset transfers, and require an offer to repurchase the notes upon certain change of control events.

  4. Gilead said it entered into an underwriting agreement on November 13, 2024 with Barclays Capital Inc. and BofA Securities, Inc., as representatives of the underwriters, and that the notes were sold in a public offering under Form S-3 shelf registration statement.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

4 series of senior notes: issue size

Gilead said it issued 4 series of senior notes in connection with the Tenth Supplemental Indenture, including 4.80% notes due 2029 at $750,000,000, 5.10% notes due 2035 at $1,000,000,000, 5.50% notes due 2054 at $1,000,000,000 and 5.60% notes due 2064 at $750,000,000.

Source · Based on the filing body and exhibits

Interest payments and maturities

The company said the notes due 2029 pay interest at 4.80% a year, the notes due 2035 at 5.10%, the notes due 2054 at 5.50% and the notes due 2064 at 5.60%, with interest paid semi-annually.

Source · Based on the filing body and exhibits

Use of net proceeds and covenants

The company said it intends to use the net proceeds from the notes for general corporate purposes, which may include repaying indebtedness. It said the indenture contains provisions that restrict secured indebtedness, sale and leaseback transactions, and consolidations, mergers or asset transfers, and require an offer to repurchase the notes upon certain change of control events.

Source · Based on the filing body and exhibits

Underwriting agreement and public offering

Gilead said it entered into an underwriting agreement on November 13, 2024 with Barclays Capital Inc. and BofA Securities, Inc., as representatives of the underwriters, and that the notes were sold in a public offering under Form S-3 shelf registration statement.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.